华熙生物
(688363)
| 流通市值：187.47亿 | | | 总市值：187.47亿 |
| 流通股本：4.82亿 | | | 总股本：4.82亿 |
| 利润表 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 营业总收入 | 829,407,051.84 | 4,199,089,274.55 | 3,163,398,568.64 | 2,260,691,517.33 |
| 营业总成本 | 752,718,280.03 | 3,825,862,023.08 | 2,850,484,222.23 | 1,981,640,358.55 |
| 其他经营收益 | | | | |
| 营业利润 | 70,898,159.16 | 333,092,312.52 | 291,698,252.81 | 261,036,071.59 |
| 利润总额 | 68,019,672.45 | 333,802,004.82 | 291,533,228 | 260,324,427.05 |
| 净利润 | 65,004,705.35 | 291,148,370.39 | 252,322,879.32 | 220,803,434.47 |
| 每股收益 | | | | |
| 其他综合收益 | -20,527,812.3 | 38,976,111.47 | 46,603,668.18 | 51,143,889.08 |
| 综合收益总额 | 44,476,893.05 | 330,124,481.86 | 298,926,547.5 | 271,947,323.55 |
| 资产负债表 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 流动资产: | | | | |
| 流动资产合计 | 2,861,528,714.58 | 2,784,992,938.78 | 2,599,935,860.65 | 2,718,781,372.73 |
| 非流动资产: | | | | |
| 非流动资产合计 | 5,888,477,275.25 | 5,907,514,385.78 | 5,869,459,045.59 | 5,854,024,415.13 |
| 资产总计 | 8,750,005,989.83 | 8,692,507,324.56 | 8,469,394,906.24 | 8,572,805,787.86 |
| 流动负债: | | | | |
| 流动负债合计 | 1,211,345,560.34 | 1,190,006,546.26 | 1,040,312,645.93 | 1,126,401,367.36 |
| 非流动负债: | | | | |
| 非流动负债合计 | 379,036,517.05 | 387,353,758.91 | 338,983,708.72 | 381,387,517.96 |
| 负债合计 | 1,590,382,077.39 | 1,577,360,305.17 | 1,379,296,354.65 | 1,507,788,885.32 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 7,129,780,906.49 | 7,085,653,979.19 | 7,059,741,796.23 | 7,032,912,753.7 |
| 股东权益合计 | 7,159,623,912.44 | 7,115,147,019.39 | 7,090,098,551.59 | 7,065,016,902.54 |
| 负债和股东权益合计 | 8,750,005,989.83 | 8,692,507,324.56 | 8,469,394,906.24 | 8,572,805,787.86 |
| 现金流量表 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 946,110,823.34 | 4,700,452,538.27 | 3,486,455,542.95 | 2,495,776,822.7 |
| 经营活动现金流出小计 | 815,150,812.66 | 4,073,002,605.95 | 3,177,696,511.82 | 2,277,444,564.79 |
| 经营活动产生的现金流量净额 | 130,960,010.68 | 627,449,932.32 | 308,759,031.13 | 218,332,257.91 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 417,466,228.34 | 463,625,517.03 | 340,184,124.12 | 92,684,934.22 |
| 投资活动现金流出小计 | 561,478,184.12 | 728,491,200.09 | 511,958,073.33 | 222,056,165.73 |
| 投资活动产生的现金流量净额 | -144,011,955.78 | -264,865,683.06 | -171,773,949.21 | -129,371,231.51 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 66,665,000 | 312,800,683.61 | 219,980,125 | 169,980,125 |
| 筹资活动现金流出小计 | 32,019,440.61 | 315,100,080.3 | 308,038,992.47 | 215,892,485.87 |
| 筹资活动产生的现金流量净额 | 34,645,559.39 | -2,299,396.69 | -88,058,867.47 | -45,912,360.87 |
| 汇率变动对现金及现金等价物的影响 | -8,475,867.36 | 3,998,656.12 | 11,025,045.21 | 12,791,476.54 |
| 现金及现金等价物净增加额 | 13,117,746.93 | 364,283,508.69 | 59,951,259.66 | 55,840,142.07 |
| 期末现金及现金等价物余额 | 990,893,663.99 | 977,775,917.06 | 673,443,668.03 | 669,332,550.44 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | 364,283,508.69 | - | 55,840,142.07 |
最新报告期：2026-07-13| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 方正证券 | 周昕,谷寒婷 | 0.86 | 1.02 | 1.19 | 2026-07-13 |